Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ciceri F"" wg kryterium: Autor


Tytuł :
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
Autorzy :
Candoni A; Hematology and SCT Unit, Università di Udine, Azienda Sanitaria-Universitaria Integrata Santa Maria Misericordia, Udine, Italy. Electronic address: .
Rambaldi A; Department of Oncology-Hematology, Universita' degli Studi di Milano e Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Fanin R; Hematology and SCT Unit, Università di Udine, Azienda Sanitaria-Universitaria Integrata Santa Maria Misericordia, Udine, Italy.
Velardi A; Hematology and Clinical Immunology, Università di Perugia, Perugia, Italy.
Arcese W; Rome Transplant Network, Università Tor Vergata, Roma, Italy.
Ciceri F; Hematology and BMT Unit, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milano, Italy.
Lazzarotto D; Hematology and SCT Unit, Università di Udine, Azienda Sanitaria-Universitaria Integrata Santa Maria Misericordia, Udine, Italy.
Lussana F; Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Bergamo, Italy.
Olivieri J; Hematology and SCT Unit, Università di Udine, Azienda Sanitaria-Universitaria Integrata Santa Maria Misericordia, Udine, Italy.
Grillo G; Department of Hematology Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy.
Parma M; Clinica Ematologica e Centro Trapianto di Midollo, Ospedale San Gerardo, Monza, Italy.
Bruno B; Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, Università di Torino,Torino, Italy; Dipartimento di Oncologia, Presidio Molinette-AOU Città della Salute e della Scienza, Trapianto Allogenico di Cellule Staminali, Torino, Italy.
Sora F; Istituto di Ematologia, Fondazione Policlinico Universitario A. Gemelli, Roma, Italy.
Bernasconi P; Centro Trapianti SC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Saccardi R; Centro Trapianti di Midollo Osseo, Careggi University Hospital, Firenze, Italy.
Foà R; Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy.
Sessa M; Institute of Hematology L. and A. Seragnoli, University Hospital S. Orsola-Malpighi, Bologna, Italy.
Bresciani P; Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy.
Giglio F; Hematology and BMT Unit, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milano, Italy.
Picardi A; Rome Transplant Network, Università Tor Vergata, Roma, Italy.
Busca A; Dipartimento di Oncologia, Presidio Molinette-AOU Città della Salute e della Scienza, Trapianto Allogenico di Cellule Staminali, Torino, Italy.
Sica S; Istituto di Ematologia, Fondazione Policlinico Universitario A. Gemelli, Roma, Italy.
Perruccio K; Hematology and Clinical Immunology, Università di Perugia, Perugia, Italy.
Zucchetti E; Department of Hematology Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy.
Diral E; Clinica Ematologica e Centro Trapianto di Midollo, Ospedale San Gerardo, Monza, Italy.
Iori AP; Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy.
Colombo AA; Centro Trapianti SC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Tringali S; UOS Trapianto di Midollo, AOR Villa Sofia-Cervello, Palermo, Italy.
Santarone S; Dipartimento di Ematologia, Medicina Trasfusionale e Biotecnologie, Ospedale Civile, Pescara, Italy.
Irrera G; Centro Unico Regionale Trapianto Cellule Staminali e Terapie Cellulari A. Neri, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
Mancini S; Centro Trapianti di Cellule Staminali, Azienda Ospedaliera San Camillo Forlanini, Roma, Italy.
Zallio F; Unità Trapianti Midollo, Azienda Ospedaliera S. Antonio e Biagio, Alessandria, Italy.
Malagola M; Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
Albano F; Dipartimento Emergenza e Trapianti di Organi, University of Bari, Bari, Italy.
Carella AM; UO Ematologia e Centro Trapianti TMO, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Olivieri A; Hematology and Bone Marrow Transplantation, University of Marche-Ospedali Riuniti, Ancona, Italy.
Tecchio C; Hematology-Bone Marrow Transplant Unit, University of Verona, Verona, Italy.
Dominietto A; UO Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Vacca A; UO Ematologia-CTMO, PO Roberto Binaghi, Cagliari, Italy.
Sorasio R; SC Ematologia, Azienda Ospedaliera S Croce e Carle, Cuneo, Italy.
Orciuolo E; UO Ematologia, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Risitano AM; BMT Unit, Department of Clinical Medicine and Surgery, Università di Napoli, Napoli, Italy.
Leotta S; Programma di Trapianto Emopoietico, Azienda Policlinico-Vittorio Emanuele, Catania, Italy.
Cortelezzi A; Università degli Studi e Ospedale Maggiore Policlinico di Milano, Milano, Italy.
Mammoliti S; GITMO Clinical Trials Office, Genova, Italy.
Oldani E; Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Bergamo, Italy.
Bonifazi F; Institute of Hematology L. and A. Seragnoli, University Hospital S. Orsola-Malpighi, Bologna, Italy.
Pokaż więcej
Corporate Authors :
GITMO
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2019 Dec; Vol. 25 (12), pp. 2388-2397. Date of Electronic Publication: 2019 Aug 07.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Philadelphia Chromosome*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Registries*
Adolescent ; Adult ; Aged ; Allografts ; Disease-Free Survival ; Female ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Societies, Medical ; Survival Rate
Czasopismo naukowe
Tytuł :
Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Autorzy :
Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Str. Wybrzeze Armii Krajowej 15, 44-101, Gliwice, Poland. .
Boumendil A; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, 84 Rue du Faubourg Saint-Antoine, 75012, Paris, France.; EBMT Acute Leukemia Working Party Office, Hospital Saint-Antoine, 84 Rue du Faubourg Saint-Antoine, 75012, Paris, France.
Labopin M; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, 84 Rue du Faubourg Saint-Antoine, 75012, Paris, France.; EBMT Acute Leukemia Working Party Office, Hospital Saint-Antoine, 84 Rue du Faubourg Saint-Antoine, 75012, Paris, France.
Seesaghur A; Amgen Limited, 1 Uxbridge Business Park, Sanderson Road, Uxbridge, London, UB8 1DH, UK.
Baron F; Department of Hematology, CHU Sart-Tilman, University of Liège, Avenue de L'Hòpital 1, 4000, Liège, Belgium.
Ciceri F; Hematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina Milano, 60, Segrate, 20132, Milan, Italy.
Esteve J; Hematology Department, IDIBAPS, Hospital Clinic, Carrer del Rosselló, 149, 08036, Barcelona, Spain.
Gorin NC; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, 84 Rue du Faubourg Saint-Antoine, 75012, Paris, France.; EBMT Acute Leukemia Working Party Office, Hospital Saint-Antoine, 84 Rue du Faubourg Saint-Antoine, 75012, Paris, France.
Savani B; Department of Hematology & Transplantation, Vanderbilt University, 2201 West End Ave, Nashville, TN, 37235, USA.
Schmid C; Department of Hematology and Oncology, Klinikum Augsburg, Ludwig-Maximilians-Universitaet Munich, Stenglinstraße 2, 86156, Augsburg, Germany.
Wetten S; Amgen Limited, 1 Uxbridge Business Park, Sanderson Road, Uxbridge, London, UB8 1DH, UK.
Mohty M; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, 84 Rue du Faubourg Saint-Antoine, 75012, Paris, France.
Nagler A; EBMT Acute Leukemia Working Party Office, Hospital Saint-Antoine, 84 Rue du Faubourg Saint-Antoine, 75012, Paris, France.; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-HaShomer, Derech Sheba 2, Ramat Gan, Israel.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2019 Oct; Vol. 98 (10), pp. 2389-2398. Date of Electronic Publication: 2019 Aug 07.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Unrelated Donors*
Hematopoietic Stem Cell Transplantation/*trends
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Transplantation Conditioning/*trends
Adolescent ; Adult ; Age Factors ; Allografts ; Autografts ; Bone Marrow Transplantation ; Europe ; Female ; Humans ; Male ; Middle Aged ; Philadelphia Chromosome ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Societies, Medical
Czasopismo naukowe
Tytuł :
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT.
Autorzy :
Piemontese S; Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy. .
Boumendil A; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.
Labopin M; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.; INSERM, UMRs 938, Paris, France.; ALWP office, Hopital Saint Antoine, Paris, France.
Schmid C; Universitätsklinik Augsburg, II Medizinische Klinik, Augsburg, Germany.
Ciceri F; Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Israel.
Arcese W; Hematology Division-Stem Cell Transplant Unit, University of Rome Tor Vergata, Rome, Italy.
Koc Y; Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey.
Gulbas Z; Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Kocaeli, Turkey.
Tischer J; LMU-University Hospital of Munich-Grosshadern, Medizinischen Klinik III, Munich, Germany.
Bruno B; A.O.U Citta della Salute e della Scienza di Torino, Presidio Molinette, Torino, Italy.
Wu D; First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China.
Blaise D; Programme de Transplantation & Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France.
Beelen D; Dept. of Bone Marrow Transplantation, University Hospital, 45122, Essen, Germany.
Irrera G; Centro Unico Regionale Trapianti, Alberto Neri, Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
Ruggeri A; Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, 00165, Roma, Italy.
Houhou M; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.; ALWP office, Hopital Saint Antoine, Paris, France.
Mohty M; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.; INSERM, UMRs 938, Paris, France.; Université Pierre et Marie Curie, Paris, France.; ALWP office, Hopital Saint Antoine, Paris, France.
Nagler A; Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; ALWP office, Hopital Saint Antoine, Paris, France.
Pokaż więcej
Corporate Authors :
Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Źródło :
Journal of hematology & oncology [J Hematol Oncol] 2019 Jul 04; Vol. 12 (1), pp. 68. Date of Electronic Publication: 2019 Jul 04.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Leukemia, Myeloid, Acute/*therapy
Neoplasm Recurrence, Local/*etiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Stem Cell Transplantation/*methods
Adolescent ; Adult ; Aged ; Female ; Humans ; Leukemia, Myeloid, Acute/epidemiology ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Retrospective Studies ; Risk Factors ; Sex Factors ; Societies, Medical ; Survival Analysis ; Transplantation, Haploidentical/methods ; Young Adult
Czasopismo naukowe
Tytuł :
Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Autorzy :
Giebel S; Maria Sklodowska-Curie Institute-Cancer Center, Gliwice Branch, Gliwice, Poland. .
Marks DI; University Hospitals Bristol National Health Service Foundation Trust, Bristol, UK.
Boissel N; Hopital St. Louis, Paris, France.
Baron F; CHU Sart-Tilman, University of Liege, Liege, Belgium.
Chiaretti S; Sapienza University, Rome, Italy.
Ciceri F; San Raffaele Scientific Institute, Milan, Italy.
Cornelissen JJ; Erasmus MC Cancer Institute University Medical Center, Rotterdam, The Netherlands.
Doubek M; University Hospital, Brno, Czechia.
Esteve J; IDIBAPS, Hospital Clinic, Barcelona, Spain.
Fielding A; North London Cancer Network, Univ. College London Hosp, London, UK.
Foa R; Sapienza University, Rome, Italy.
Gorin NC; EBMT Acute Leukemia Working Party Office, Paris, France.; Hospital Saint-Antoine, Paris, France.
Gökbuget N; Maria Sklodowska-Curie Institute-Cancer Center, Gliwice Branch, Gliwice, Poland.; Hopital St. Louis, Paris, France.
Hallböök H; Uppsala University, Uppsala, Sweden.
Hoelzer D; University Hospital, Goethe University, Frankfurt, Germany.
Paravichnikova E; FGBU Hematology Research Center, Russia Federation Ministry of Public Health, Moscow, Russia.
Ribera JM; ICO-Hospital Germans Trias I Pujol, Jose Carreras Research Institute, Badalona, Spain.
Savani B; Vanderbilt University Medical Center, Nashville, USA.
Rijneveld AW; Erasmus MC Cancer Institute University Medical Center, Rotterdam, The Netherlands.
Schmid C; Klinikum Augsburg, Ludwig-Maximilians-Universitaet, Munich-Augsburg, Germany.
Wartiovaara-Kautto U; Helsinki University Hospital, Helsinki, Finland.
Mohty M; North London Cancer Network, Univ. College London Hosp, London, UK.; EBMT Acute Leukemia Working Party Office, Paris, France.
Nagler A; North London Cancer Network, Univ. College London Hosp, London, UK.; Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Dombret H; Hopital St. Louis, Paris, France.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2019 Jun; Vol. 54 (6), pp. 798-809. Date of Electronic Publication: 2018 Nov 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*methods
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Transplantation Conditioning/*methods
Europe ; Female ; Humans ; Male ; Prospective Studies ; Remission Induction
Czasopismo naukowe
Tytuł :
Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
Autorzy :
Shimoni A; Division of Hematology, Chaim Sheba Medical Center, Tel-Hashomer and Sackler Medical School, Tel-Aviv University, Tel-Aviv, Israel. .
Labopin M; Acute Leukemia Working Party Office, Paris, France.
Lorentino F; Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy.
Van Lint MT; Department of Haematology II, Ospedale San Martino, Genova, Italy.
Koc Y; Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey.
Gülbas Z; Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Kocaeli, Turkey.
Tischer J; Department of Internal Medicine III, LMU Munich Campus Grosshadern, Munich, Germany.
Bruno B; S.S.C.V.D. Trapianto di Cellule Staminali A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy.
Blaise D; Programme de Transplantation and Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
Pioltelli P; Ospedale San Gerardo, Clinica Ematologica dell'Universita Milano-Biocca, Monza, Italy.
Afanasyev B; First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research, Institute for Paediatric Oncology, Hematology and Transplantation, St Petersburg, Russia.
Ciceri F; Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy.
Mohty M; Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France.
Nagler A; Division of Hematology, Chaim Sheba Medical Center, Tel-Hashomer and Sackler Medical School, Tel-Aviv University, Tel-Aviv, Israel.; Acute Leukemia Working Party Office, Paris, France.
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2019 Jan; Vol. 33 (1), pp. 230-239. Date of Electronic Publication: 2018 Jun 15.
Typ publikacji :
Journal Article
MeSH Terms :
Cyclophosphamide/*therapeutic use
Graft vs Host Disease/*mortality
Hematopoietic Stem Cell Transplantation/*mortality
Killer Cells, Natural/*immunology
Leukemia, Myeloid, Acute/*mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*mortality
Receptors, KIR/*immunology
Adult ; Aged ; Female ; Follow-Up Studies ; Graft vs Host Disease/genetics ; Graft vs Host Disease/immunology ; Graft vs Host Disease/therapy ; Histocompatibility ; Humans ; Immunosuppressive Agents/therapeutic use ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/immunology ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy ; Prognosis ; Receptors, KIR/genetics ; Retrospective Studies ; Survival Rate ; Transplantation Conditioning ; Transplantation, Haploidentical ; Young Adult
Czasopismo naukowe
Tytuł :
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.
Autorzy :
Ruggeri A; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.
Labopin M; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.; INSERM, UMRs 938, Paris, France.
Bacigalupo A; Ospedale San Martino, Department of Hematology II, Genova, Italy.
Gülbas Z; Anadolu Medical Center Hospital, Bone Marrow Transplantation Department, Kocaeli, Turkey.
Koc Y; Medical Park Hospitals, Stem Cell Transplant Unit, Antalya, Turkey.
Blaise D; Programme de Transplantation & Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France.
Bruno B; A.O.U Citta della Salute e della Scienza di Torino, Presidio Molinette, Torino, Italy.
Irrera G; Centro Unico Regionale Trapianti, Alberto Neri, Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
Tischer J; LMU-University Hospital of Munich-Grosshadern, Medizinischen Klinik III, Munich, Germany.
Diez-Martin JL; Instituto de Investigacion Sanitaria Gregorio Marañon, Division of Hematology, Hospital Gregorio Marañon, Universidad Complutense, Medicina, Madrid, Spain.
Castagna L; Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Ciceri F; Ospedale San Raffaele, Haematology and BMT, Milano, Italy.
Mohty M; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.; INSERM, UMRs 938, Paris, France.; Université Pierre et Marie Curie, Paris, France.
Nagler A; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer; Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło :
Cancer [Cancer] 2018 Apr 01; Vol. 124 (7), pp. 1428-1437. Date of Electronic Publication: 2018 Jan 23.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Bone Marrow Transplantation/*mortality
Cyclophosphamide/*therapeutic use
Graft vs Host Disease/*mortality
Leukemia, Myeloid, Acute/*therapy
Peripheral Blood Stem Cell Transplantation/*mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adolescent ; Adult ; Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Graft vs Host Disease/prevention & control ; Humans ; Leukemia, Myeloid, Acute/immunology ; Leukemia, Myeloid, Acute/pathology ; Male ; Middle Aged ; Myeloablative Agonists/therapeutic use ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Prognosis ; Retrospective Studies ; Survival Rate ; Transplantation Conditioning ; Transplantation, Haploidentical ; Young Adult
Czasopismo naukowe
Tytuł :
Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Autorzy :
Santoro N; Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint Antoine, 75012, Paris, France. .; Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy. .
Ruggeri A; Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint Antoine, 75012, Paris, France.
Labopin M; Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint Antoine, 75012, Paris, France.; ALWP office, Hôpital Saint-Antoine, Paris, France.
Bacigalupo A; Department of Hematology II, Ospedale San Martino, Genova, Italy.; Università cattolica del Sacro Cuore, Roma, Italy.
Ciceri F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Gülbaş Z; Hematology Department, Anadolu Medical Center Hospital, Kocaeli, Turkey.
Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Afanasyev B; Hematology and Transplantology, Ratsa Gorbacheva Memorial Children's Institute, Saint Petersburg State Medical Pavlov University, St. Petersburg, Russian Federation.
Arcese W; Stem Cell Transplant Unit, Department of Hematology, Tor Vergata 'University Hospital', Rome, Italy.
Wu D; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Koc Y; Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey.
Tischer J; Department of Internal Medicine III, Hematopoietic Stem Cell Transplantation, Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Munich, Germany.
Santarone S; Department of Hematology and Trasfusional Medicine, Lund University, Ospedale Civile, Pescara, Italy.
Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Comprehensive Cancer Center M. Sklodowska-Curie Memorial Institute, Gliwice Branch, Gliwice, Poland.
Mohty M; Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint Antoine, 75012, Paris, France.
Nagler A; ALWP office, Hôpital Saint-Antoine, Paris, France.; Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel.
Pokaż więcej
Źródło :
Journal of hematology & oncology [J Hematol Oncol] 2017 May 30; Vol. 10 (1), pp. 113. Date of Electronic Publication: 2017 May 30.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*methods
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adolescent ; Adult ; Aged ; Female ; Graft vs Host Disease/epidemiology ; Graft vs Host Disease/prevention & control ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/epidemiology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Prognosis ; Retrospective Studies ; Survival Analysis ; Transplantation Conditioning/methods ; Transplantation, Homologous/methods ; Young Adult
Czasopismo naukowe
Tytuł :
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Autorzy :
Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland. .
Czyz A; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
Ottmann O; Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom.
Baron F; Department of Hematology, Centre Hospitalier Universitaire Sart-Tilman, University of Liege, Belgium, France.
Brissot E; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
Ciceri F; Hematology and Bone Marrow Transplantation (BMT) Unit, San Raffaele Scientific Institute, Milan, Italy.
Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Esteve J; Hematology Department, August Pi i Sunyer Institute for Biomedical Research, Hospital Clinic, Barcelona, Spain.
Gorin NC; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
Savani B; Department of Hematology and Transplantation, Vanderbilt University, Nashville, Tennessee.
Schmid C; Department of Hematology and Oncology, Klinikum Augsburg, Ludwig-Maximilians-Universitaet, Munich, Augsburg, Germany.
Mohty M; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Office, Hospital Saint-Antoine, Paris, France.
Pokaż więcej
Źródło :
Cancer [Cancer] 2016 Oct; Vol. 122 (19), pp. 2941-51. Date of Electronic Publication: 2016 Jun 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Philadelphia Chromosome*
Hematopoietic Stem Cell Transplantation/*adverse effects
Neoplasm Recurrence, Local/*drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Protein Kinase Inhibitors/*therapeutic use
Humans ; Neoplasm Recurrence, Local/etiology ; Societies, Medical
Czasopismo naukowe
Tytuł :
Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
Autorzy :
Salmoiraghi S; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Montalvo ML; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Ubiali G; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Tosi M; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Peruta B; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Zanghi P; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Oldani E; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Boschini C; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Kohlmann A; Personalized Healthcare and Biomarkers, Innovative Medicines and Early Development, AstraZeneca, Cambridge, UK.
Bungaro S; Centro Ricerche Tettamanti, Clinica Pediatrica Università Milano-Bicocca, Ospedale San Gerardo, Monza, Italy.
Intermesoli T; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Terruzzi E; Divisione di Ematologia e Trapianto di Midollo Osseo, Ospedale San Gerardo, Monza, Italy.
Angelucci E; Ematologia e Centro Trapianti, Ospedale Oncologico di Riferimento Regionale 'Armando Businco', Azienda Ospedaliera 'Brotzu', Cagliari, Italy.
Cavattoni I; Ematologia e Centro Trapianti di Midollo Osseo, Ospedale Centrale, Bolzano, Italy.
Ciceri F; Hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Bassan R; Hematology, Ospedale dell'Angelo, Mestre-Venezia, Italy.
Rambaldi A; Dipartimento Scienze Cliniche e di Comunità, University of Milan, Italy Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy .
Spinelli O; Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2016 Jun; Vol. 101 (6), pp. e245-8. Date of Electronic Publication: 2016 Mar 18.
Typ publikacji :
Clinical Trial; Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Tumor Suppressor Protein p53/*genetics
Adult ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Survival Rate
Raport
Tytuł :
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.
Autorzy :
Rubio MT; Service d'Hématologie et de Thérapie cellulaire, Saint Antoine Hospital, Paris, France. .; INSERM UMR 938, Paris, France. .; Université Pierre et Marie Curie, Paris, France. .; Acute Leukemia Working Party of EBMT, Paris, France. .
Savani BN; Acute Leukemia Working Party of EBMT, Paris, France.; Vanderbilt University Medical Center, Nashville, TN, USA.
Labopin M; Service d'Hématologie et de Thérapie cellulaire, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France.; EBMT Paris study office/CEREST-TC, Paris, France.
Piemontese S; Acute Leukemia Working Party of EBMT, Paris, France.; Ospedale San Raffaele s.r.l., Ematologia, Milan, Italy.
Polge E; Service d'Hématologie et de Thérapie cellulaire, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France.; EBMT Paris study office/CEREST-TC, Paris, France.
Ciceri F; Ospedale San Raffaele s.r.l., Ematologia, Milan, Italy.
Bacigalupo A; Department of Haematology II, Ospedale San Martino, Genoa, Italy.
Arcese W; Rome Transplant Network, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy.
Koc Y; Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey.
Beelen D; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
Gülbas Z; Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Kocaeli, Turkey.
Wu D; Department of Hematology, First Affiliated Hospital of Soochow University, Suzhou, China.
Santarone S; Ospedale Civile BMT Center, Pescara, Italy.
Tischer J; Department of Internal Medicine III, Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Munich, Germany.
Afanasyev B; SPb State I. Pavlov Medical University, St. Petersburg, Russia.
Schmid C; Klinikum Augsburg, University of Munich, Munich, Germany.
Giebel S; Department of Bone Marrow Transplantation and Hemato-Oncology, Cancer Center, Gliwice, Poland.
Mohty M; Service d'Hématologie et de Thérapie cellulaire, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France.; EBMT Paris study office/CEREST-TC, Paris, France.
Nagler A; Université Pierre et Marie Curie, Paris, France.; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Pokaż więcej
Źródło :
Journal of hematology & oncology [J Hematol Oncol] 2016 Mar 15; Vol. 9, pp. 25. Date of Electronic Publication: 2016 Mar 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*methods
Leukemia, Myeloid/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Transplantation Conditioning/*methods
Acute Disease ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide/administration & dosage ; Cytarabine/administration & dosage ; Disease-Free Survival ; Female ; Graft vs Host Disease/prevention & control ; Humans ; Male ; Melphalan/administration & dosage ; Middle Aged ; Multivariate Analysis ; Mycophenolic Acid/administration & dosage ; Mycophenolic Acid/analogs & derivatives ; Neoplasm Recurrence, Local ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study.
Autorzy :
Shouval R; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.; Internal medicine 'F' Department and the 2013 Pinchas Borenstein Talpiot Medical Leadership Program, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.; The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Labopin M; EBMT Paris Office, Hospital Saint Antoine, Paris, France.; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France.; INSERM, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France.; AP-HP, Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France.
Unger R; The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Giebel S; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Ciceri F; Hematology and BMT Unit, San Raffaele Scientific Institute, Milan, Italy.
Schmid C; Department of Hematology and Oncology, Klinikum Augsburg, Ludwig-Maximilians-University, Munich, Germany.
Esteve J; Hematology Department, IDIBAPS, Hospital Clínic, Barcelona, Spain.
Baron F; Hematology & GIGA research, University of Liège, Liège, Belgium.
Gorin NC; EBMT Paris Office, Hospital Saint Antoine, Paris, France.
Savani B; Hematology & Stem Cell Transplantation Section, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Shimoni A; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
Mohty M; EBMT Paris Office, Hospital Saint Antoine, Paris, France.; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France.; INSERM, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France.; AP-HP, Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France.
Nagler A; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.; EBMT Paris Office, Hospital Saint Antoine, Paris, France.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2016 Mar 04; Vol. 11 (3), pp. e0150637. Date of Electronic Publication: 2016 Mar 04 (Print Publication: 2016).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*adverse effects
Leukemia, Myeloid, Acute/*mortality
Leukemia, Myeloid, Acute/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adult ; Algorithms ; Area Under Curve ; Computer Simulation ; Data Collection ; Data Mining ; Europe ; Female ; Humans ; Machine Learning ; Male ; Middle Aged ; Predictive Value of Tests ; Recurrence ; Remission Induction ; Retrospective Studies ; Societies, Medical ; Transplantation Conditioning ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Autorzy :
Savani BN; Vanderbilt University Medical Center, Nashville, TN, USA .
Labopin M; EBMT Paris Study Office/CEREST-TC, Paris, France Department of Haematology, Saint Antoine Hospital, Paris, France INSERM UMR 938, Paris, France Université Pierre et Marie Curie, Paris, France.
Blaise D; Département d'Hématologie - Centre de Recherche en Cancérologie de Marseille - Aix-Marseille University, Institut Paoli Calmettes, Marseille, France.
Niederwieser D; University Hospital Leipzig, Hematology, Oncology and Hemostaseology Divisions, Germany.
Ciceri F; Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Ganser A; Hannover Medical School - Department of Haematology Hemostasis Oncology and Stem Cell Transplantation, Hannover, Germany.
Arnold R; Charité Universitätsmedizin Berlin, Campus Virchow Klinikum - Medizinische Klinik m. S. Hämatologie/Onkologie, Berlin, Germany.
Afanasyev B; Saint Petersburg State Medical Pavlov University, Ratsa Gorbacheva Memorial Children's Institute, Hematology and Transplantology, St. Petersburg, Russia.
Vigouroux S; CHU Bordeaux - Hôpital Haut-leveque, Pessac, France.
Milpied N; CHU Bordeaux - Hôpital Haut-leveque, Pessac, France.
Hallek M; University of Cologne, Department of Medicine, Germany.
Cornelissen JJ; ErasmusMC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Schwerdtfeger R; Department of Haematology, Oncology Helios-Klinikum Berlin-Buch, Germany.
Polge E; EBMT Paris Study Office/CEREST-TC, Paris, France Department of Haematology, Saint Antoine Hospital, Paris, France INSERM UMR 938, Paris, France Université Pierre et Marie Curie, Paris, France.
Baron F; Department of Medicine, Division of Hematology, University of Liège, Belgium.
Esteve J; Department of Hematology, Hospital Clinic, Barcelona, Spain.
Gorin NC; Department of Hematology, Saint Antoine Hospital, APHP and University UPMS, Paris, France.
Schmid C; Klinikum Augsburg, Department of Hematology and Oncology, University of Munich, Augsburg, Germany.
Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland.
Mohty M; EBMT Paris Study Office/CEREST-TC, Paris, France Department of Haematology, Saint Antoine Hospital, Paris, France INSERM UMR 938, Paris, France Université Pierre et Marie Curie, Paris, France.
Nagler A; EBMT Paris Study Office/CEREST-TC, Paris, France Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2016 Feb; Vol. 101 (2), pp. 256-62. Date of Electronic Publication: 2015 Nov 12.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Bone Marrow Transplantation*
Peripheral Blood Stem Cell Transplantation*
Registries*
Graft vs Host Disease/*diagnosis
Leukemia, Myeloid, Acute/*diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis
Transplantation Conditioning/*methods
Adolescent ; Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Female ; Graft vs Host Disease/genetics ; Graft vs Host Disease/mortality ; Graft vs Host Disease/prevention & control ; Humans ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/mortality ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy ; Prognosis ; Recurrence ; Remission Induction ; Retrospective Studies ; Survival Analysis ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study.
Autorzy :
Shouval R; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium. .
Labopin M; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Bondi O; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Mishan-Shamay H; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Shimoni A; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Ciceri F; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Esteve J; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Giebel S; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Gorin NC; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Schmid C; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Polge E; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Aljurf M; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Kroger N; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Craddock C; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Bacigalupo A; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Cornelissen JJ; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Baron F; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Unger R; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Nagler A; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Mohty M; Roni Shouval, Hila Mishan-Shamay, Avichai Shimoni, and Arnon Nagler, The Chaim Sheba Medical Center, Tel-Hashomer; Roni Shouval, Ori Bondi, and Ron Unger, Bar-Ilan University, Ramat-Gan, Israel; Myriam Labopin, Norbert C. Gorin, Emmanuelle Polge, Arnon Nagler, and Mohamad Mohty, European Group for Blood and Marrow Transplantation; Myriam Labopin and Mohamad Mohty, Sorbonne Universités, Centre de Recherche (CDR) Saint-Antoine; Myriam Labopin and Mohamad Mohty, Institut National de la Santé et de la Recherche Médicale, CDR Saint-Antoine; Myriam Labopin and Mohamad Mohty, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France; Fabio Ciceri, San Raffaele Scientific Institute, Milan; Andrea Bacigalupo, Ospedale San Martino, Genoa, Italy; Jordi Esteve, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Sebastian Giebel, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christoph Schmid, Ludwig-Maximilians-University, Munich; Nicolaus Kroger, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Mahmoud Aljurf, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Charles Craddock, Queen Elizabeth Hospital, Birmingham, United Kingdom; Jan J. Cornelissen, Erasmus University Medical Center, Rotterdam, the Netherlands; and Frederic Baron, University of Liège, Liège, Belgium.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2015 Oct 01; Vol. 33 (28), pp. 3144-51. Date of Electronic Publication: 2015 Aug 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Algorithms*
Data Mining*
Decision Support Techniques*
Machine Learning*
Hematopoietic Stem Cell Transplantation/*mortality
Leukemia, Myeloid, Acute/*surgery
Postoperative Complications/*mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*surgery
Adult ; Area Under Curve ; Decision Trees ; Disease Progression ; Disease-Free Survival ; Europe/epidemiology ; Female ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Logistic Models ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Predictive Value of Tests ; ROC Curve ; Registries ; Reproducibility of Results ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
Autorzy :
Ruggeri A; Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, AP-HP, Paris, France.; INSERM, UMRs 938, Paris, France.; Hôpital Saint Louis, Eurocord, IUH University Paris VII, Paris, France.
Labopin M; Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, AP-HP, Paris, France.; Hôpital Saint Antoine, Université Pierre and Marie Curie, Paris, France.
Sanz G; Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Piemontese S; Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy.
Arcese W; Rome Transplant Network, University Tor Vergata, Rome, Italy.
Bacigalupo A; Dipartimento di Ematologia, Ospedale San Martino, Genova, Italy.
Blaise D; Institut Paoli Calmettes, Marseille, France.
Bosi A; Careggi University Hospital, Firenze, Italy.
Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Karakasis D; Evangelismos Hospital, Division of Hematology, BMT Unit, Athens, Greece.
Koc Y; Stem Cell Transplant Unit, Medical Park, Antalya, Turkey.
Michallet M; Hôpital Edouard Herriot, Lyon, France.
Picardi A; Rome Transplant Network, University Tor Vergata, Rome, Italy.
Sanz J; Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Santarone S; Ospedale Civile, Dipartimento di Ematologia, BMT Unit, Pescara, Italy.
Sengelov H; Rigshospitalet, Copenhagen, Denmark.
Sierra J; Hospital Santa Creu i Sant Pau, Jose Carreras Institute, Universitat Autonoma de Barcelona, Barcelona, Spain.
Vincent L; CHU Montpellier, Montpellier, France.
Volt F; Hôpital Saint Louis, Eurocord, IUH University Paris VII, Paris, France.
Nagler A; Chaim Sheba Medical Center, Tel-Hashomer, Israel.; ALWP Office Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, AP-HP, Paris, France.
Gluckman E; Hôpital Saint Louis, Eurocord, IUH University Paris VII, Paris, France.; Monacord, Centre Scientifique de Monaco, Monaco, France.
Ciceri F; Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy.
Rocha V; Hôpital Saint Louis, Eurocord, IUH University Paris VII, Paris, France.; Churchill Hospital, Oxford University, Oxford, UK.
Mohty M; Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, AP-HP, Paris, France.; INSERM, UMRs 938, Paris, France.; Hôpital Saint Antoine, Université Pierre and Marie Curie, Paris, France.
Pokaż więcej
Corporate Authors :
Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology working party-EBMT
ALWP-EBMT study
Źródło :
Leukemia [Leukemia] 2015 Sep; Vol. 29 (9), pp. 1891-900. Date of Electronic Publication: 2015 Apr 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cord Blood Stem Cell Transplantation*
Hematopoietic Stem Cell Transplantation*
HLA Antigens/*immunology
Leukemia, Myeloid, Acute/*immunology
Leukemia, Myeloid, Acute/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adolescent ; Adult ; Aged ; Female ; Follow-Up Studies ; Graft Survival ; Graft vs Host Disease/etiology ; Graft vs Host Disease/prevention & control ; Histocompatibility Testing ; Humans ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Recurrence ; Risk Factors ; Transplantation Conditioning ; Transplantation, Homologous ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Haploidentical HSCT: a 15-year experience at San Raffaele.
Autorzy :
Bonini C; Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.
Peccatori J; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Stanghellini MT; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Vago L; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Bondanza A; Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.
Cieri N; Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.
Greco R; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Bernardi M; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Corti C; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Oliveira G; Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.
Zappone E; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Traversari C; MolMed SpA, Milan, Italy.
Bordignon C; 1] MolMed SpA, Milan, Italy [2] 'Vita-Salute' San Raffaele University, Milan, Italy.
Ciceri F; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 Suppl 2, pp. S67-71.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphocyte Transfusion*
Graft vs Host Disease/*prevention & control
Hematopoietic Stem Cell Transplantation/*methods
Leukemia, Myeloid, Acute/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
T-Lymphocytes/*transplantation
Allografts ; Female ; Genetic Engineering ; Humans ; Male
Czasopismo naukowe
Tytuł :
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia.
Autorzy :
Piemontese S; 1] Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy [2] EBMT Paris Office, Hosital Saint Antoine, Paris, France.
Ciceri F; 1] Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy [2] EBMT Paris Office, Hosital Saint Antoine, Paris, France.
Labopin M; 1] EBMT Paris Office, Hosital Saint Antoine, Paris, France [2] AP-HP, Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France [3] Sorbonne Niversité, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, Paris, France [4] INSERM, MR_S 938, CDR Saint-Antoine, Paris, France.
Bacigalupo A; Division of Hematology II, IRCCS, San Martino University Hospital-IST, Genoa, Italy.
Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Santarone S; Department of Hematology, Ospedale Civile, Pescara, Italy.
Gorin NC; 1] EBMT Paris Office, Hosital Saint Antoine, Paris, France [2] AP-HP, Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France [3] Sorbonne Niversité, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, Paris, France [4] INSERM, MR_S 938, CDR Saint-Antoine, Paris, France.
Koc Y; Hematopoietic Stem Cell Transplantation Unit, Medical Park Hospital, Antalya, Turkey.
Wu D; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, China.
Beelen D; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
Tischer J; University Hospital of Munich-Klinikum Grosshadern (LMU), Department of Internal Medicine III, Hematopoietic Cell Transplantation, Munich, Germany.
Ehninger G; Medizinische Klinik und Poliklinik I, Universitaetsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany.
Arcese W; Stem Cell Transplant Unit, Fondazione Policlinico Tor Vergata, Tor Vergata University, Rome, Italy.
Nagler A; 1] EBMT Paris Office, Hosital Saint Antoine, Paris, France [2] Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Mohty M; 1] EBMT Paris Office, Hosital Saint Antoine, Paris, France [2] AP-HP, Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France [3] Sorbonne Niversité, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, Paris, France [4] INSERM, MR_S 938, CDR Saint-Antoine, Paris, France.
Pokaż więcej
Corporate Authors :
Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT)
Źródło :
Leukemia [Leukemia] 2015 May; Vol. 29 (5), pp. 1069-75. Date of Electronic Publication: 2014 Dec 01.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease/*immunology
Hematopoietic Stem Cell Transplantation/*methods
Leukemia, Myeloid, Acute/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adolescent ; Adult ; Aged ; Alleles ; Antibodies, Monoclonal/immunology ; Disease-Free Survival ; Female ; Histocompatibility Testing ; Humans ; Leukemia, Myeloid, Acute/metabolism ; Lymphocyte Depletion ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism ; Recurrence ; Remission Induction ; Stem Cell Transplantation ; Time Factors ; Transplantation Conditioning/methods ; Transplantation, Homologous ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia.
Autorzy :
Bassan R; 1] UOC Ematologia, Ospedale dell'Angelo, Mestre-Venezia, Italy [2] USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Spinelli O; USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Oldani E; USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Intermesoli T; USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Tosi M; USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Peruta B; USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Borlenghi E; Divisione di Ematologia, Spedali Civili, Brescia, Italy.
Pogliani EM; Clinica Ematologica, Ospedale San Gerardo, Monza, Italy.
Di Bona E; UOC Ematologia, Ospedale S. Bortolo, Vicenza, Italy.
Cassibba V; Divisione di Ematologia, Ospedale Civile, Bolzano, Italy.
Scattolin AM; UOC Ematologia, Ospedale dell'Angelo, Mestre-Venezia, Italy.
Romani C; UO Ematologia, Ospedale Oncologico di Riferimento Regionale, Cagliari, Italy.
Ciceri F; UO Ematologia, Istituto Scientifico H.S. Raffaele, Milano, Italy.
Cortelezzi A; UO Ematologia I, IRCCS Ca' Granda Ospedale Maggiore Policlinico and Università degli Studi, Milano, Italy.
Gianfaldoni G; Ematologia, Università di Firenze, AOU Careggi, Firenze, Italy.
Mattei D; SC Ematologia, ASO S. Croce e Carle, Cuneo, Italy.
Audisio E; Ematologia 2, Ospedale San Giovanni Battista/Università, Torino, Italy.
Rambaldi A; USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Pokaż więcej
Źródło :
Blood cancer journal [Blood Cancer J] 2014 Jul 11; Vol. 4, pp. e225. Date of Electronic Publication: 2014 Jul 11.
Typ publikacji :
Letter
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*methods
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adolescent ; Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplasm, Residual ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Transplantation Conditioning/methods ; Treatment Outcome ; Young Adult
Opinia redakcyjna
Tytuł :
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.
Autorzy :
Lepore M; Experimental Immunology, Department of Biomedicine, University Hospital Basel; Nuclear Magnetic Resonance Laboratory, Department of Chemistry; and Department of Biochemistry, Biozentrum; University of Basel, 4056 Basel, Switzerland Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
de Lalla C; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Gundimeda SR; Experimental Immunology, Department of Biomedicine, University Hospital Basel; Nuclear Magnetic Resonance Laboratory, Department of Chemistry; and Department of Biochemistry, Biozentrum; University of Basel, 4056 Basel, Switzerland.
Gsellinger H; Experimental Immunology, Department of Biomedicine, University Hospital Basel; Nuclear Magnetic Resonance Laboratory, Department of Chemistry; and Department of Biochemistry, Biozentrum; University of Basel, 4056 Basel, Switzerland.
Consonni M; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Garavaglia C; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Sansano S; Experimental Immunology, Department of Biomedicine, University Hospital Basel; Nuclear Magnetic Resonance Laboratory, Department of Chemistry; and Department of Biochemistry, Biozentrum; University of Basel, 4056 Basel, Switzerland.
Piccolo F; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Scelfo A; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Häussinger D; Experimental Immunology, Department of Biomedicine, University Hospital Basel; Nuclear Magnetic Resonance Laboratory, Department of Chemistry; and Department of Biochemistry, Biozentrum; University of Basel, 4056 Basel, Switzerland.
Montagna D; Laboratorio di Immunologia, Dipartimento di Pediatria, Università di Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Locatelli F; Department of Pediatric Hematology-Oncology, IRCCS Bambino Gesù Hospital, 00165 Rome, Italy.
Bonini C; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Bondanza A; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Forcina A; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Li Z; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
Ni G; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
Ciceri F; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Jenö P; Experimental Immunology, Department of Biomedicine, University Hospital Basel; Nuclear Magnetic Resonance Laboratory, Department of Chemistry; and Department of Biochemistry, Biozentrum; University of Basel, 4056 Basel, Switzerland.
Xia C; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
Mori L; Experimental Immunology, Department of Biomedicine, University Hospital Basel; Nuclear Magnetic Resonance Laboratory, Department of Chemistry; and Department of Biochemistry, Biozentrum; University of Basel, 4056 Basel, Switzerland Singapore Immunology Network (SIgN), Agency for Science, Technology, and Research, Singapore 138648 .
Dellabona P; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy .
Casorati G; Experimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy .
De Libero G; Experimental Immunology, Department of Biomedicine, University Hospital Basel; Nuclear Magnetic Resonance Laboratory, Department of Chemistry; and Department of Biochemistry, Biozentrum; University of Basel, 4056 Basel, Switzerland Singapore Immunology Network (SIgN), Agency for Science, Technology, and Research, Singapore 138648 .
Pokaż więcej
Źródło :
The Journal of experimental medicine [J Exp Med] 2014 Jun 30; Vol. 211 (7), pp. 1363-77. Date of Electronic Publication: 2014 Jun 16.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunologic Surveillance*
Antigens, CD1/*immunology
Autoantigens/*immunology
Blast Crisis/*immunology
Glycoproteins/*immunology
Leukemia, Myeloid, Acute/*immunology
Lysophospholipids/*immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*immunology
T-Lymphocytes/*immunology
Adolescent ; Animals ; Antigen Presentation/genetics ; Antigen Presentation/immunology ; Antigens, CD1/genetics ; Autoantigens/genetics ; Blast Crisis/genetics ; Blast Crisis/pathology ; Child ; Child, Preschool ; Female ; Gene Expression Regulation, Leukemic/genetics ; Gene Expression Regulation, Leukemic/immunology ; Glycoproteins/genetics ; Humans ; Jurkat Cells ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/pathology ; Lysophospholipids/genetics ; Male ; Mice ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; T-Lymphocytes/pathology
Czasopismo naukowe
Tytuł :
Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT.
Autorzy :
Chevallier P; Centre Hospitalier et Universitaire (CHU) de Nantes, Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Université de Nantes and INSERM CRNCA UMR, Nantes, France. />Labopin M
Buchholz S
Ganser A
Ciceri F
Lioure B
Faul C
Guillerm G
Finke J
Huynh A
Schubert J
Kolb HJ
Polge E
Nagler A
Mohty M
Pokaż więcej
Źródło :
European journal of haematology [Eur J Haematol] 2012 Sep; Vol. 89 (3), pp. 214-9. Date of Electronic Publication: 2012 Aug 09.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Stem Cell Transplantation*
Transplantation Conditioning*
Adenine Nucleotides/*administration & dosage
Arabinonucleosides/*administration & dosage
Leukemia, Myeloid, Acute/*surgery
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*surgery
Adolescent ; Adult ; Aged ; Clofarabine ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma.
Autorzy :
Cortelazzo S; Division of Hematology, Ospedale Civile, Bolzano, Italy.
Intermesoli T
Oldani E
Ciceri F
Rossi G
Pogliani EM
Mattei D
Romani C
Cortelezzi A
Borlenghi E
Corti C
Peruta B
Spinelli O
Rambaldi A
Bassan R
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2012 Jan; Vol. 91 (1), pp. 73-82. Date of Electronic Publication: 2011 May 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Mediastinum/*radiation effects
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*radiotherapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*surgery
Radiotherapy, Image-Guided/*methods
Stem Cell Transplantation/*methods
Adolescent ; Adult ; Female ; Humans ; Male ; Mediastinum/pathology ; Middle Aged ; Neoplasm, Residual/drug therapy ; Neoplasm, Residual/pathology ; Neoplasm, Residual/surgery ; Risk Factors ; Survival Rate ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies